Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Guest

Showing results (141-150 of 149) with videos related to

Pageof 15
Sort By:
You have reached the last page of results.This site can display upto 149 results.
Haematologica|February 17, 2022
Outstanding outcomes in infants with <i>KMT2A</i>-germline acute lymphoblastic leukemia treated with chemotherapy alone: results of the Children's Oncology Group AALL0631 trialErin M Guest, John A Kairalla, Joanne M Hilden, et al.
Genetics in Medicine : Official Journal of the American College of Medical Genetics|February 10, 2021
Deep phenotyping in 3q29 deletion syndrome: recommendations for clinical careRossana Sanchez Russo, Michael J Gambello, Melissa M Murphy, et al.
Blood|December 5, 2021
Single-cell multiomics reveals increased plasticity, resistant populations, and stem-cell-like blasts in KMT2A-rearranged leukemiaChangya Chen, Wenbao Yu, Fatemeh Alikarami, et al.
Haematologica|June 13, 2024
Azacitidine as epigenetic priming for chemotherapy is safe and well-tolerated in infants with newly diagnosed <i>KMT2A</i>-rearranged acute lymphoblastic leukemia: Children's Oncology Group trial AALL15P1Erin M Guest, John A Kairalla, Meenakshi Devidas, et al.
Medrxiv : the Preprint Server for Health Sciences|January 13, 2025
Successful classification of clinical pediatric leukemia genetic subtypes via structural variant detection using HiFi long-read sequencingLisa A Lansdon, Byunggil Yoo, Ayse Keskus, et al.
NPJ Genomic Medicine|April 9, 2026
Proof-of-concept study for the detection of somatic structural variant driver alterations using HiFi long-read sequencing in a pediatric leukemia cohortLisa A Lansdon, Byunggil Yoo, Ayse Keskus, et al.
Leukemia|November 15, 2022
Preclinical efficacy of azacitidine and venetoclax for infant KMT2A-rearranged acute lymphoblastic leukemia reveals a new therapeutic strategyLaurence C Cheung, Carlos Aya-Bonilla, Mark N Cruickshank, et al.
Blood Advances|May 17, 2022
Real-world use of tisagenlecleucel in infant acute lymphoblastic leukemiaAmy Moskop, Lauren Pommert, Christina Baggott, et al.
The Lancet. Haematology|February 1, 2023
Racial and ethnic disparities in childhood and young adult acute lymphocytic leukaemia: secondary analyses of eight Children's Oncology Group cohort trialsSumit Gupta, Yunfeng Dai, Zhiguo Chen, et al.
Pageof 15

Showing results (141-150 of 149) with videos related to

Sort By:
Pageof 15
You have reached the last page of results.This site can display upto 149 results.
Haematologica|February 17, 2022
Outstanding outcomes in infants with <i>KMT2A</i>-germline acute lymphoblastic leukemia treated with chemotherapy alone: results of the Children's Oncology Group AALL0631 trialErin M Guest, John A Kairalla, Joanne M Hilden, et al.
Genetics in Medicine : Official Journal of the American College of Medical Genetics|February 10, 2021
Deep phenotyping in 3q29 deletion syndrome: recommendations for clinical careRossana Sanchez Russo, Michael J Gambello, Melissa M Murphy, et al.
Blood|December 5, 2021
Single-cell multiomics reveals increased plasticity, resistant populations, and stem-cell-like blasts in KMT2A-rearranged leukemiaChangya Chen, Wenbao Yu, Fatemeh Alikarami, et al.
Haematologica|June 13, 2024
Azacitidine as epigenetic priming for chemotherapy is safe and well-tolerated in infants with newly diagnosed <i>KMT2A</i>-rearranged acute lymphoblastic leukemia: Children's Oncology Group trial AALL15P1Erin M Guest, John A Kairalla, Meenakshi Devidas, et al.
Medrxiv : the Preprint Server for Health Sciences|January 13, 2025
Successful classification of clinical pediatric leukemia genetic subtypes via structural variant detection using HiFi long-read sequencingLisa A Lansdon, Byunggil Yoo, Ayse Keskus, et al.
NPJ Genomic Medicine|April 9, 2026
Proof-of-concept study for the detection of somatic structural variant driver alterations using HiFi long-read sequencing in a pediatric leukemia cohortLisa A Lansdon, Byunggil Yoo, Ayse Keskus, et al.
Leukemia|November 15, 2022
Preclinical efficacy of azacitidine and venetoclax for infant KMT2A-rearranged acute lymphoblastic leukemia reveals a new therapeutic strategyLaurence C Cheung, Carlos Aya-Bonilla, Mark N Cruickshank, et al.
Blood Advances|May 17, 2022
Real-world use of tisagenlecleucel in infant acute lymphoblastic leukemiaAmy Moskop, Lauren Pommert, Christina Baggott, et al.
The Lancet. Haematology|February 1, 2023
Racial and ethnic disparities in childhood and young adult acute lymphocytic leukaemia: secondary analyses of eight Children's Oncology Group cohort trialsSumit Gupta, Yunfeng Dai, Zhiguo Chen, et al.
Pageof 15